Award
National Cancer Institute 1R61CA302550-01
High throughput multidimensional chemoproteomics for function-directed covalent target discovery
Recipient
Not specified
Award Amount
$649,181.00
Ceiling
$649,181.00
Awarded
August 07, 2025
Identifier
1R61CA302550-01
Award for developing proteomic methods to identify therapeutic protein targets using chemoproteomics, funded by the National Cancer Institute.
Description
The project involves high throughput multidimensional chemoproteomics for covalent target discovery. It aims to develop new proteomic approaches to discover therapeutically relevant proteins targeted by cysteine-reactive molecules. The project is funded by the National Cancer Institute under grant RFA-CA-24-008 and is part of the translational research and cancer research spending categories. The project duration is from August 8, 2025, to July 31, 2028.